BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India EP News Bureau Jul 26, 2021 Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy…
